← back to search

Antonio Colaprico

University of Miami · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Bioinformatics and Genomic Networks, and Ferroptosis and cancer prognosis.
h-index
37
citations
26,011
works
114
NIH funding
primary concept
Biology
email

Recent publications

Precision proteogenomics reveals pan-cancer impact of germline variants
Cell 2025cited by 6position: middledoi
Pan-cancer proteogenomics characterization of tumor immunity
Cell 2024cited by 84position: middledoi
Proteogenomic data and resources for pan-cancer analysis
Cancer Cell 2023cited by 216position: middledoi
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Cell 2023cited by 179position: middledoi
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Cancer Cell 2023cited by 100position: middledoi
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Cell 2023cited by 99position: middledoi
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Cell Reports Medicine 2023cited by 31position: middledoi
IoT sensor nodes for air pollution monitoring: A review
ACTA IMEKO 2023cited by 11position: middledoi
A workflow to study mechanistic indicators for driver gene prediction with Moonlight.
2023cited by 7position: contributordoi
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Cancer Cell 2022cited by 202position: middledoi
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer
Oncogene 2022cited by 45position: middledoi
Proteogenomic and metabolomic characterization of human glioblastoma
Cancer Cell 2021cited by 683position: middledoi
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Cell 2021cited by 584position: middledoi
A proteogenomic portrait of lung squamous cell carcinoma
Cell 2021cited by 384position: middledoi
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
Cancer Cell 2021cited by 376position: middledoi
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Nature Communications 2021cited by 254position: middledoi
PathwayMultiomics: An R Package for Efficient Integrative Analysis of Multi-Omics Datasets With Matched or Un-matched Samples
Frontiers in Genetics 2021cited by 17position: middledoi
LR Hunting: A Random Forest Based Cell–Cell Interaction Discovery Method for Single-Cell Gene Expression Data
Frontiers in Genetics 2021cited by 17position: middledoi
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Cell 2020cited by 810position: middledoi
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Cell 2020cited by 546position: middledoi
Proteogenomic Characterization of Endometrial Carcinoma
Cell 2020cited by 528position: middledoi
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.
2020cited by 445position: contributordoi
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Cell 2020cited by 339position: middledoi
Interpreting pathways to discover cancer driver genes with Moonlight
Nature Communications 2020cited by 105position: firstdoi
PathwayPCA: an R/Bioconductor Package for Pathway Based Integrative Analysis of Multi‐Omics Data
PROTEOMICS 2020cited by 15position: middledoi
The Immune Landscape of Cancer
Immunity 2019cited by 799position: middledoi
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Cell 2019cited by 767position: middledoi
New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx
PLoS Computational Biology 2019cited by 596position: middledoi
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia
Cancer Discovery 2019cited by 212position: middledoi
The Immune Landscape of Cancer
Immunity 2018cited by 6,153position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tiago C. Silva · Healthpoint6 papers (2019–2021)Yuguang Ban · University of Miami4 papers (2020–2022)Gabriel Odom · Florida International University3 papers (2020–2021)Houtan Noushmehr · Cancer Genetics (United States)3 papers (2018–2020)X. Steven Chen · Jishou University3 papers (2021–2021)Xiaodian Sun · University of Miami3 papers (2020–2022) · 2 papers (2019–2020)Brian D. Lehmann · Vanderbilt University Medical Center2 papers (2021–2021)Gianluca Bontempi · University of Edinburgh2 papers (2019–2020)Elena Papaleo · Cancer Institute (WIA)2 papers (2019–2020)Bing Zhang · North Sichuan Medical University2 papers (2020–2021)Lily Wang · Western University2 papers (2021–2021) · 2 papers (2020–2023)María E. Figueroa · University of Miami2 papers (2018–2019)Larsson Omberg · Sage Bionetworks1 papers (2018–2018)Tingting Qin · Ann Arbor Center for Independent Living1 papers (2019–2019) · 1 papers (2020–2020)Jenaro García‐Huidobro · University of Talca1 papers (2018–2018) · 1 papers (2020–2020)Joerg Huelsken · University of Lausanne1 papers (2018–2018)